KaydedilenlerDerginizi ekleyin

Dergiler / Eurasian Journal of Pulmonology / 2020 / Cilt: 22 - Sayı: 2

Management of bleeding risk before pleural procedures: A consensus statement of Turkish respiratory society – Pleura study group

Deniz KOKSAL
Cansel ATİNKAYA
Nilgun Yilmaz DEMİRCİ
Semra BİLACEROGLU
Nalan OGAN
Mustafa OZHAN
Guntulu AK
Sayfa
73–78
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The management of bleeding complication is out of the scope of this statement.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Pleural effusion is a common clinical entity.
📊
Temel Bulgular & Veri:Pleural procedures performed for the diagnosis and management of pleural effusions may increase the risk of bleeding, especially in patients with coagulopathies and comorbidities and those in need for antithrombotic drugs.
💡
Sonuç & Katkı:The management of bleeding complication is out of the scope of this statement.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Pleural effusion is a common clinical entity. Pleural procedures performed for the diagnosis and management of pleural effusions may increase the risk of bleeding, especially in patients with coagulopathies and comorbidities and those in need for antithrombotic drugs. Current literature provides sparse, low level of evidence, which is insufficient for safe implementation of pleural procedures among these patients. Thoracentesis, pleural biopsy (closed or percutaneous), catheter or chest tube drainage, and thoracoscopy are the main pleural procedures performed in these patients. Considering the bleeding risk associated with a specific pleural procedure, the risk is low for thoracentesis, moderate for insertion or removal of the chest tube or tunneled catheter, and moderate high for pleural biopsies and thoracoscopy. The current statement is prepared mainly for the pulmonologists and intended to provide recommendations to reduce the risk of bleeding following pleural procedures. The management of bleeding complication is out of the scope of this statement.

🔖

Bu Makaleye Atıf Yap

KOKSAL, D., ATİNKAYA, C., DEMİRCİ, N. Y., BİLACEROGLU, S., OGAN, N., OZHAN, M., AK, G. (2022). Management of bleeding risk before pleural procedures: A consensus statement of Turkish respiratory society – Pleura study group. Eurasian Journal of Pulmonology, Cilt: 22 - Sayı: 2, 73–78. https://ajindex.com/articles/509628

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Cantey EP, Walter JM, Corbridge T, Barsuk JH. Complications of thoracentesis: Incidence, risk factors, and strategies for prevention. Curr Opin Pulm Med 2016;22:378‑85
  2. Havelock T, Teoh R, Laws D, Gleeson F: BTS Pleural Disease Guideline Group. Pleural procedures and thoracic ultrasound: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010;65 Suppl 2:61‑76
  3. Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image‑guided interventions. J Vasc Interv Radiol 2012;23:727‑36
  4. Göğüs Hastalıkları Uzmanları Için Plevra Hastaliklari Tani Ve Tedavi Rehberi. TTD Ve TÜSAD Yayını. Ankara; 2016. p. 1‑53
  5. Peri‑Procedure Management of Anticoagulants. Available from: https://www.mdanderson.org›dam›algorithms. [Last accessed on 2020 Jan 10]
  6. Management of Antiplatelet Therapy in Patients with Cardiac Stents Undergoing Procedures. Available from: https://www.mdanderson.org›dam›algorithms. [Last accessed on 2020 Jan 10]
  7. Hermana DD, Thomsonb CC, Brosnhanc S, Pateld R, Trosini‑Deserte V, Bilaceroglu S, et al. Risk of bleeding in patients undergoing pulmonary procedures on antiplatelet or anticoagulants: A systematic review. Respir Med 2019;153:76‑84
  8. Wolfe KS, Kress JP. Risk of procedural hemorrhage. Chest 2016;150:237‑46
  9. Intagliata NM, Argo CK, Stine JG, Lisman T, Caldwell SH, Violi F. On behalf of the faculty of the 7th International Coagulation in Liver Disease. Concepts in coagulation in liver disease: A summary of the 7th International Coagulation In Liver Disease Conference. Thromb Haemost 2018;118:1491‑506
  10. Kumar S, Lim E, Covic A, Verhamme P, Gale CP, Camm AJ, et al. Anticoagulation in concomitant chronic kidney disease and atrial fibrillation: JACC review topic of the week. J Am Coll Cardiol 2019;74:2204‑15
  11. Ault MJ, Rosen BT, Scher J, Feinglass J, Barsuk JH. Thoracentesis outcomes: A 12‑year experience. Thora×2015;70:127‑32
  12. Patel MD, Joshi SD. Abnormal preprocedural international normalized ratio and platelet counts are not associated with increased bleeding complications after ultrasound‑guided thoracentesis. AJR Am J Roentgenol 2011;197:W164‑8
  13. Puchalski JT, Argento AC, Murphy TE, Araujo KL, Pisani MA. The safety of thoracentesis in patients with uncorrected bleeding risk. Ann Am Thorac Soc 2013;10:336‑41
  14. Patel PA, Ernst FR, Gunnarsson CL. Ultrasonography guidance